Literature DB >> 34173895

Act Healthy: A Randomized Clinical Trial Evaluating a Behavioral Activation Intervention to Address Substance Use and Medication Adherence Among Low-Income, Black/African American Individuals Living with HIV/AIDS.

Jessica F Magidson1, Jennifer M Belus2, C J Seitz-Brown2, Hannah Tralka2, Steven A Safren3, Stacey B Daughters4.   

Abstract

There is a need for parsimonious behavioral interventions to support HIV and substance use treatment outcomes for low-income, Black/African American individuals living with HIV. This randomized clinical trial (N = 61) evaluated Act Healthy (AH), an integrated behavioral intervention to reduce substance use and improve medication adherence, compared to supportive counseling (SC) plus Life-Steps medication adherence counseling on substance use, craving, adherence-related outcomes, and depression over one year. Participants in AH had significantly steeper decreases in cravings compared to SC, but no significant differences in substance use. Across both groups, there was a significant increase in probability of being on antiretroviral therapy (ART) (86% on ART at 12 months vs. 56% at baseline), and a significant decrease in medication nonadherence. Findings provide preliminary support for an intervention to reduce cravings and strategies to improve ART use in a hard-to-reach, vulnerable population at high risk for poor treatment outcomes and ongoing HIV transmission. TRIAL REGISTRATION: ClinicalTrials.gov trial registration number: identifier: NCT01351454. Retrospectively registered on May 10, 2011.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Behavioral intervention; HIV/AIDS; Health disparities; Minority health; Substance use disorder

Mesh:

Year:  2021        PMID: 34173895      PMCID: PMC8808422          DOI: 10.1007/s10461-021-03354-1

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  56 in total

1.  Relapse outcomes in a randomized trial of residential and day drug abuse treatment.

Authors:  G L Greenwood; W J Woods; J Guydish; E Bein
Journal:  J Subst Abuse Treat       Date:  2001-01

2.  Racial residential segregation: a fundamental cause of racial disparities in health.

Authors:  D R Williams; C Collins
Journal:  Public Health Rep       Date:  2001 Sep-Oct       Impact factor: 2.792

3.  A comprehensive pharmacologic-psychosocial treatment program for HIV-seropositive cocaine- and opioid-dependent patients. Preliminary findings.

Authors:  S K Avants; A Margolin; D DePhilippis; T R Kosten
Journal:  J Subst Abuse Treat       Date:  1998 May-Jun

Review 4.  Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.

Authors:  Raye Z Litten; Bonnie B Wilford; Daniel E Falk; Megan L Ryan; Joanne B Fertig
Journal:  Subst Abus       Date:  2016 Apr-Jun       Impact factor: 3.716

5.  High prevalence of substance use among heterosexuals living in communities with high rates of AIDS and poverty in Washington, DC.

Authors:  Irene Kuo; Alan E Greenberg; Manya Magnus; Gregory Phillips; Anthony Rawls; James Peterson; Flora Hamilton; Tiffany West-Ojo; Shannon Hader
Journal:  Drug Alcohol Depend       Date:  2011-02-12       Impact factor: 4.492

6.  Examining the effect of the Life Enhancement Treatment for Substance Use (LETS ACT) on residential substance abuse treatment retention.

Authors:  Jessica F Magidson; Stephanie M Gorka; Laura MacPherson; Derek R Hopko; Carlos Blanco; C W Lejuez; Stacey B Daughters
Journal:  Addict Behav       Date:  2011-01-21       Impact factor: 3.913

7.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.

Authors:  E G Bing; M A Burnam; D Longshore; J A Fleishman; C D Sherbourne; A S London; B J Turner; F Eggan; R Beckman; B Vitiello; S C Morton; M Orlando; S A Bozzette; L Ortiz-Barron; M Shapiro
Journal:  Arch Gen Psychiatry       Date:  2001-08

8.  Antiretroviral Medication Adherence and Amplified HIV Transmission Risk Among Sexually Active HIV-Infected Individuals in Three Diverse International Settings.

Authors:  Jessica F Magidson; Xin Li; Matthew J Mimiaga; Ayana T Moore; Kriengkrai Srithanaviboonchai; Ruth Khalili Friedman; Mohammad Limbada; James P Hughes; Vanessa Cummings; Charlotte A Gaydos; Vanessa Elharrar; David Celentano; Kenneth H Mayer; Steven A Safren
Journal:  AIDS Behav       Date:  2016-04

9.  Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners.

Authors:  Sandra A Springer; Jingjun Qiu; Ali Shabahang Saber-Tehrani; Frederick L Altice
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

10.  Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial.

Authors:  Steven A Safren; C Andres Bedoya; Conall O'Cleirigh; Katie B Biello; Megan M Pinkston; Michael D Stein; Lara Traeger; Erna Kojic; Gregory K Robbins; Jonathan A Lerner; Debra S Herman; Matthew J Mimiaga; Kenneth H Mayer
Journal:  Lancet HIV       Date:  2016-09-19       Impact factor: 12.767

View more
  1 in total

1.  Health Care Consumption, Psychiatric Diagnoses, and Pharmacotherapy 1 and 2 Years Before and After Newly Diagnosed HIV: A Case-Control Study Nested in The Greater Stockholm HIV Cohort Study.

Authors:  Per Wändell; Gunnar Ljunggren; Amadou Jallow; Lars Wahlström; Axel C Carlsson
Journal:  Psychosom Med       Date:  2022-08-20       Impact factor: 3.864

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.